CR3 Keyless Split Sample Cup Nortriptyline-Buprenorphine— 510(k) K142609

Substantially Equivalent

Guangzhou Wondfo Biotech Co., Ltd.

FDA 510(k) clearance K142609 for CR3 Keyless Split Sample Cup Nortriptyline-Buprenorphine, Substantially Equivalent on 2014-12-18. Applicant: Guangzhou Wondfo Biotech Co., Ltd..

Clearance details

Applicant: Guangzhou Wondfo Biotech Co., Ltd.
Product code: Code LFG
Advisory panel: Clinical Toxicology
Date received: 2014-09-16
Decision date: 2014-12-18
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Guangzhou, CN

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.